Answers are grounded in this paper and cite their sources.
CRISPR-based diagnostics have evolved from proof-of-concept nucleic acid assays to increasingly integrated platforms for streamlined canonical/non-canonical single or multiplex target detection with digital quantification. Here we review these advances according to their ability to regulate Cas activity and dissect key checkpoints of CRISPR activation. We also organize advanced CRISPR-based diagnostic systems by their use of four regulatory dimensions: activation-threshold control, reaction compatibility and temporal coordination, spatial organization, and catalytic signal transduction. This framework reveals common mechanisms and limitations underlying current engineering strategies and provides a conceptual foundation for predictable, standardizable, and clinically translatable Cas activity engineering.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: